OxisResearch Introduces New Spin Trap for Free Radical Detection.Business/Medical Editors PORTLAND, Ore.--(BUSINESS WIRE)--April 24, 2001 OxisResearch, a division of OXIS Health Products, Inc.(Nasdaq:OXIS), announces the release of a new spin trap, EMPO. Spin trapping is a method by which researchers can measure free radicals via electron paramagnetic resonance electron paramagnetic resonance: see magnetic resonance. spectroscopy (EPR EPR Electron Paramagnetic Resonance EPR Extended Producer Responsibility EPR Electronic Patient Record(s) EPR Emergency Preparedness and Response (US DHS) EPR Endpoint Reference EPR Ethylene-Propylene Rubber ). The use of spin traps is becoming increasingly important in the study of oxidative stress oxidative stress, n an imbalance of the prooxidant antioxidant ratio in which too few antioxidants are produced or ingested or too many oxidizing agents are produced. , allowing a direct and definitive measurement of these free radicals. With the development of more cost-effective instrumentation, the applications of spin trapping will diversify and grow. The new spin trap EMPO is an addition to the current line of spin traps already available from OXIS. These products include DEPMPO and PBN PBN Paint By Number PBN Procurement Business Number PBN Pyrolytic Boron Nitride PBN Policy-Based Networking PBN Performance-Based Navigation PBN Progressive Bengali Network PBN Paintball Nation PBN Permanent Background Notices , both of which are widely used by researchers and clinical investigators. "Reactive oxygen species reactive oxygen species, n molecules and ions of oxygen that have an unpaired electron, thus rendering them extremely reactive. Many cellular structures are susceptible to attack by ROS contributing to cancer, heart disease, and cerebrovascular disease. are damaging molecules involved in human degenerative diseases," said OxisResearch Senior Scientist Dr. Jie Sun. "We hope that novel spin traps will aid research in this area by simplifying free radical detection." OXIS Health Products, Inc is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of OXIS International, Inc. (NASDAQ and Nouveau Marche:OXIS) located in Portland, Oregon. The company is dedicated to developing technologies to treat and prevent diseases associated with damage from free radicals and reactive oxygen species-- diseases of oxidative stress. OXIS International seeks to partner its discoveries for development of new therapies for these diseases. For additional information about OXIS Research and OXIS Health Products, please visit the company's website at: http://www.oxisresearch.com or call 1-800-547-3686. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion